Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient.
Mattei
D
D
Bassan
R
R
Mordini
N
N
Rapezzi
D
D
Rambaldi
A
A
Strola
G
G
Peretti
C
C
Del Grosso
F
F
Ferraris
A M
AM
Castellino
C
C
Gallamini
A
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology; D049109:Cell Proliferation; D041321:Chromosomes, Human, X / Q000235:genetics / Q000276:immunology; D036101:Cord Blood Stem Cell Transplantation; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology; D017809:Fatal Outcome; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects; D006085:Graft Survival / Q000276:immunology; D006086:Graft vs Host Disease / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D045823:Ileus / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D000069285:Infliximab; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications* / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D018365:Neoplasm, Residual; D054448:Precursor Cells, B-Lymphoid / Q000276:immunology / Q000473:pathology*; D018183:Transplantation Chimera / Q000235:genetics / Q000276:immunology; D019172:Transplantation Conditioning
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069285:Infliximab